Skip to main content
SpringerLink
Log in

Stereotactically Guided Fractionated Re-irradiation in Recurrent Glioblastoma Multiforme

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Purpose. To assess the feasibility, efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent glioblastoma multiforme.

Patients and Methods. From January 1995 to July 2003, 53 patients with histologically proven glioblastoma multiforme were treated at recurrence with fractionated stereotactic radiation therapy. A median dose of 36 Gy using a median fractionation of 5 × 2 Gy/week was applied.

Results. Median overall survival was 21 months, and median overall survival from the time point of re-irradiation was 8 months. The median time interval between primary and secondary radiation therapy was 10 months. In this patient population, no variables predicting longer overall survival could be determined. However, neurosurgical resection at relapse was associated with increased survival after re-irradiation (p=0.04), but left progression-free survival unaltered. Treatment was well-tolerated and no severe toxicities developed.

Conclusion. Stereotactically guided fractionated re-irradiation is a safe and effective treatment modality in selected cases of recurring glioblastoma multiforme. Since this is not a randomized study, further evaluation in larger patient collectives is warranted. Also, based on recent results of radiochemotherapy in the treatment of primary glioblastoma multiforme, concomitant chemotherapy at relapse might be considered in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. MD Walker TA Strike GE Sheline (1979) ArticleTitleAn analysis of dose-effect relationship in the radiotherapy of malignant gliomas Int J Radiat Oncol Biol Phys 5 1725–1731 Occurrence Handle231022

    PubMed  Google Scholar 

  2. DF Nelson M Diener-West J Horton et al. (1988) ArticleTitleCombined modality approach to treatment of malignant gliomas- re-evaluation of RTOG 7401/ECOG 1374 with long term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group NCI Monogr 6 279–284 Occurrence Handle3281031

    PubMed  Google Scholar 

  3. NM Bleehen SP Stenning (1991) ArticleTitleA Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma The Medical Research Council Brain Tumor Working Party. Br J Cancer 64 769–774

    Google Scholar 

  4. F Fauchon L Davila G Chantellier D Fohanno J Philippon A Rey J Chiras M Poisson Y Delattre (1990) ArticleTitleTreatmenet of malignant gliomas with surgery, intra-arterial infusions of 1-(2-Hydeoxyethyl)chlorethylnitrosourea and radiation therapy: A phase II study Neurosurgery 27 231–234 Occurrence Handle10.1097/00006123-199008000-00010 Occurrence Handle2385341

    Article  PubMed  Google Scholar 

  5. PH Gutin MD Prados TL Phillips WM Wara DA Larson SA Leibel PK Sneed VA Levin KA Weaver P Silver K Lamborn SA Lamb B Ham (1991) ArticleTitleExternal irradiation followed by an interstitial high activity iodine-125 implant ‘boost’ in the initial treatment of malignant gliomas:NCOG Study 6G-82-2 Int J Radiat Oncol Biol Phys 21 601–606 Occurrence Handle1651302

    PubMed  Google Scholar 

  6. JS Loeffler E. Alexander SuffixIII WM Shea PY Wen WA Fine HM Kooy PM Black (1992) ArticleTitleRadiosurgery as part of the initial management of patients with malignant gliomas J Clin Oncol 10 1379–1385 Occurrence Handle1325539

    PubMed  Google Scholar 

  7. MD Prados PH Gutin TL Phillips WM Wara PK Sneed DA Larson SA Lamb B Ham MK Malec CB Wilson (1991) ArticleTitleInterstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience Int J Radiat Oncol Biol Phys 24 593–597

    Google Scholar 

  8. N Sakai H Yamada T Andoh T Hirata Y Nishimura Y Miwa K Shimizu S. Yanagawa (1991) ArticleTitleIntraoperative radiation therapy for malignant glioma Neurol Med Chir 31 702–707

    Google Scholar 

  9. K Watne O Nome B Hager H Hirschberg (1991) ArticleTitleCombined intra-arterial chemotherapy and irradiation of malignant glioma Acta Oncol 3 835–841

    Google Scholar 

  10. M Weller B Muller R Koch M Bamberg P Krauseneck (2003) ArticleTitleNeuro-Oncology Working Group of the German Cancer Society. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma J Clin Oncol 21 IssueID17 3276–3284 Occurrence Handle10.1200/JCO.2003.03.509 Occurrence Handle12947063

    Article  PubMed  Google Scholar 

  11. SE Combs S Gutwein D Schulz-Ertner M Kampen Particlevan C Thilmann L Edler MM Wannenmacher J Debus (2005) ArticleTitleTemozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme phase I/II study Strahlenther Onkol. 181 IssueID6 372–377 Occurrence Handle10.1007/s00066-005-1359-x Occurrence Handle15925979

    Article  PubMed  Google Scholar 

  12. PK Sneed PH Gutin DA Larson MK Malec TL Phillips MD Prados CO Scharfen KA Weaver WM Wara (1994) ArticleTitlePatterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost Int J Radiat Oncol Biol Phys 29 719–727 Occurrence Handle8040017

    PubMed  Google Scholar 

  13. M Kampen Particlevan R Engenhart-Cabillic J Debus M Fuss B Rhein M Wannenmacher (1998) ArticleTitleThe radiosurgery of glioblastoma multiforme in cases of recurrence. The Heidelberg experiences compared to the literature. Strahlenther Onkologie 174 IssueID1 19–24

    Google Scholar 

  14. M Kampen Particlevan R Engenhart-Cabillic J Debus M Fuss B Rhein M. Wannenmacher (1998) ArticleTitleValue of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature. Strahlenther Onkologie 174 IssueID4 187–192

    Google Scholar 

  15. A Höss J Debus R Bendl R Engenhadt-Cabillic W Schlegel (1995) ArticleTitleComputerized procedures in 3-dimensional radiotherapy planning Radiologe 35 583–586 Occurrence Handle8588040

    PubMed  Google Scholar 

  16. EL Kaplan P. Meier (1958) ArticleTitleNonparametric estimation from incomplete observations J Am Stat Assoc 53 457–81

    Google Scholar 

  17. TG Clark MJ Bradburn SB. Love DG Altman (2003) ArticleTitleSurvival Analysis Part I: Basic concepts and first analyses Br J Cancer 89 232–238 Occurrence Handle10.1038/sj.bjc.6601118 Occurrence Handle12865907

    Article  PubMed  Google Scholar 

  18. TG Clark MJ Bradburn SB. Love DG Altman (2003) ArticleTitleSurvival Analysis Part II: Multivatiate data analysis- an introduction to concepts and methods Br J Cancer 89 431–436 Occurrence Handle10.1038/sj.bjc.6601119 Occurrence Handle12888808

    Article  PubMed  Google Scholar 

  19. KK Herfarth S Gutwein J Debus (2001) ArticleTitlePostoperative radiotherapy of astrocytomas Semin Surg Oncol 20 IssueID1 13–23 Occurrence Handle10.1002/ssu.1012 Occurrence Handle11291128

    Article  PubMed  Google Scholar 

  20. M Deutsch SB Green TA Strike PC Burger JT Robertson RG Selker WR Shapiro J Mealy J Ransohoff SuffixII P Paoletti K Smith GL Odom WE Hunt B Young E Alexander MD Walker DA Pistenmaa (1989) ArticleTitleResults of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiation therapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma Int J Radiat Oncol Biol Phys 16 1389–1396 Occurrence Handle2542193

    PubMed  Google Scholar 

  21. Stupp R, Mason WP, Van Den Bent MJ, Weller M. Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group. ASCO 2004, Abstract #3

  22. WKA Yung RE Albright J Olson R Fredericks K Fink MD Prados M Brada A Spence RJ Hohl W Shapiro M Glantz H Greenberg RG Selker NA Vick R Rampling H Friedmann P Phillips J Bruner N Yue D Osoba S Zaknoen VA Levin (2000) ArticleTitleA phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J of Cancer 83 588–593 Occurrence Handle10.1054/bjoc.2000.1316

    Article  Google Scholar 

  23. MC Chamberlain P. Kormanik (1999) ArticleTitleSalvage chemotherapy with Taxol for recurrent anaplastic astrocytomas J Neuro-Oncol 43 71–78 Occurrence Handle10.1023/A:1006277631745

    Article  Google Scholar 

  24. ES Bower NM Newlands M Bleehen et al. (1997) ArticleTitleMulticentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma Cancer Chemother Pharmacol 40 484–488 Occurrence Handle10.1007/s002800050691 Occurrence Handle9332462

    Article  PubMed  Google Scholar 

  25. J Dinnes CB Cave S Huang K Major RM Milne (2001) ArticleTitleThe effectiveness and cost- effectiveness of temozolomide for the treatment of recurrent malignant glioma Health Technol Assess 5 IssueID13 1–73

    Google Scholar 

  26. Jaeckle KA, Hess KR, Yung WKA, Greenberg H, Fine H, Schiff D, Pollack IF, Kuhn J, Fink K, Mehta M, Cloughesy T, Nicholas MK, Chang S, Prados M: Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the treatment of recurrent and progressive malignant glioma North Am Br Tumor Consortium Study 21(12): 2305–2311, 2003

  27. GS Bauman PK Sneed WM Wara LJ Stalpers SM Chang MW McDermott PH Gutin DA Larson (1996) ArticleTitleReirradiation of primary CNS tumors Int J Radiat Oncol Biol Phys 36 433–441 Occurrence Handle10.1016/S0360-3016(96)00315-X Occurrence Handle8892469

    Article  PubMed  Google Scholar 

  28. KH Cho WA Hall BJ Gerbi PD Higgins WA McGuire HBC Clark (1999) ArticleTitleSingle dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas Int J Radiat Oncol Biol Phys 45 IssueID5 1133–1141 Occurrence Handle10.1016/S0360-3016(99)00336-3 Occurrence Handle10613305

    Article  PubMed  Google Scholar 

  29. RW Laing AP Warrington J Graham J Britton F Hines M. Brada (1993) ArticleTitleEfficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study) Radiotherapy Oncol 27 22–29 Occurrence Handle10.1016/0167-8140(93)90040-F

    Article  Google Scholar 

  30. M Brada K Hoang-Xuang R Rampling PY Dietrich L Dirix D Macdonald J Heimans B Zonnenberg J Bravo-Marques R Henrikson R Stupp N Yue J Bruner M Dugan S Rao S Zaknoen (2001) ArticleTitleMulticenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 259–266 Occurrence Handle10.1023/A:1008382516636 Occurrence Handle11300335

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, German Cancer Research Center (DKFZ), INF 280, Heidelberg, Germany

    S. E. Combs, Ch. Thilmann, P. Huber, J. Debus & D. Schulz-Ertner

  2. Department of Radiation Oncology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany

    S. E. Combs, S. Gutwein, Ch. Thilmann, P. Huber, J. Debus & D. Schulz-Ertner

Authors
  1. S. E. Combs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Gutwein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ch. Thilmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Debus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Schulz-Ertner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. E. Combs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Combs, S.E., Gutwein, S., Thilmann, C. et al. Stereotactically Guided Fractionated Re-irradiation in Recurrent Glioblastoma Multiforme. J Neurooncol 74, 167–171 (2005). https://doi.org/10.1007/s11060-004-2463-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-2463-y

Keywords

Search

Navigation